Anticoagulation and Antiplatelet Management During Perioperative Period : a Daily Practice Cohort Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,400
- 试验地点
- 1
- 主要终点
- Ratio of well treated patient
研究概览
简要总结
the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.
详细描述
the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.
the investigators want to investigate these transitions: how were they understood by patients, how were they performed, and how does this affect surgery, postoperative morbidity and mortality?
Anticoagulation for prevention of thromboembolic events will not be studied in this study.
The anesthesia team will not be particularly trained in anticoagulants and antiplatelets management to be close to actual care. In the Hospital the investigators have a guide written in 2013 in order to describe all the cases possible. The "control/ goal group" will be the patients who have undertaken strictly the protocol described for their cases in the guide.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients over 18 years old
- •Able to consent
- •Taking anticoagulants or antiplatelet drugs in the long term.
排除标准
- •Incapacitated adults
- •Minor patients
结局指标
主要结局
Ratio of well treated patient
时间窗: 30 days
Ratio of well treated patient
次要结局
- bleeding consequence (volume in mL)(30 days)
- Mortality Consequence(30 Days)
- Blood Test Consequence(30 Days)
- Morbidity(30 days)